GENE THERAPY FOR TREATMENT OF SPINAL CORD INJURY

这个子项目是许多利用资源的研究子项目之一 由NIH/NCRR资助的中心拨款提供。子项目的主要支持 而子项目的主要调查员可能是由其他来源提供的， 包括其它NIH来源。 列出的子项目总成本可能 代表子项目使用的中心基础设施的估计数量， 而不是由NCRR赠款提供给子项目或子项目工作人员的直接资金。 脊髓损伤（SCI）目前困扰着40万美国人，并且没有有效的治疗方法来促进功能恢复。需要新的治疗方法来促进SCI后的再生和恢复。我们已经开发了一种灵长类动物SCI模型，该模型满足产生清晰和一致的解剖和功能缺陷的目标，同时保持受试者的一般活动性和舒适性。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Spinal cord injury (SCI) currently afflicts 400,000 Americans and there exist no effective therapies for promoting recovery of function. New therapies to promote regeneration and recovery after SCI are needed. We have developed a model of primate SCI that meets the goals of generating clear and consistent anatomical and functional deficits, while maintaining general mobility and comfort of the subject.